| Literature DB >> 27682832 |
G Pini1,2, S Bigoni3, L Congiu4, A M Romanelli5, M F Scusa4, P Di Marco4, A Benincasa4, P Morescalchi4, A Ferlini3, F Bianchi5, D Tropea6, M Zappella4.
Abstract
BACKGROUND: Rett Syndrome is a neurodevelopmental disorder almost exclusively affecting females, characterized by a broad clinical spectrum of signs and symptoms and a peculiar course. The disease affects different body systems: nervous, muscolo-skeletal, gastro-enteric. Moreover, part of the symptoms are related to the involvement of the autonomic nervous system. In the Tuscany Rett Center at Versilia Hospital, we collected data from 151 subjects with a clinical diagnosis of classical or variant RTT syndrome. For each subject, we assessed the severity of the condition with clinical-rating scales (ISS, PBZ), we quantified the performance of the autonomic nervous system, and we performed genetic analysis. We used multivariate statistical analysis of the data to evaluate the relation between the different clinical RTT forms, the cardiorespiratory phenotype, the different genetic mutations and the severity of the clinical picture. Individuals were classified according to existing forms: Classical RTT and three atypical RTT: Z-RTT, Hanefeld, Congenital. A correlation between C-Terminal deletions and lower severity of the clinical manifestations was evident, in the previous literature, but, considering the analysis of autonomic behaviour, the original classification can be enriched with a more accurate subdivision of Rett subgroups, which may be useful for early diagnosis.Entities:
Keywords: ARTT-NOS: Atypical RTT-not otherwise specified; CDKL5: Cyclin dependent kinase-like 5; FOXG1: Forkhead box G1; MECP2: Methyl CpG binding protein 2; RTT: Rett syndrome; Z-RTT: Preserved speech variant or “Zappella variant”
Year: 2016 PMID: 27682832 PMCID: PMC5041273 DOI: 10.1186/s13023-016-0499-7
Source DB: PubMed Journal: Orphanet J Rare Dis ISSN: 1750-1172 Impact factor: 4.123
Sample description—Clinical forms, age at the evaluation and age at diagnosis
| Clinical forms | N. | % | Age at the evaluation | Age at the diagnosis |
|---|---|---|---|---|
| Classical | 98 | 64,9 | 12,5 (10,2) | 6,7 (8,5) |
| Z-RTT | 19 | 12,6 | 12,5 (7,9) | 7,3 (5,6) |
| Hanefeld | 13 | 8,6 | 6,1 (4,8) | 2,6 (1,7) |
| Congenital | 1 | 0,7 | 2 | 1 |
| ARTT-NOS | 20 | 13,2 | 13,5 (9,5) | 8,45 (4,8) |
| Total | 151 | 100 | – | – |
Clinical forms and ISS total score, percentage
| ISS total | % Classical | % Z-RTT | % Hanefeld | % Congenital | % ARTT-NOS |
|---|---|---|---|---|---|
| Mean (SD) | 19.5 (5.9) | 11.7 (3.7) | 19.4 (4.8) | 26 | 21.4 (6) |
Subscale growth and development and clinical forms
| % Classical | % Z-RTT | % Hanefeld | % ARTT-NOS | |
|---|---|---|---|---|
| Height | ||||
| <3rd centile | 39 | 5 | 17 | 60 |
| 3rd–40th centile | 48 | 47 | 58 | 15 |
| >40th centile | 13 | 48 | 25 | 25 |
| Weight | ||||
| <3rd centile | 40 | 10 | 17 | 60 |
| 3rd–40th centile | 35 | 21 | 58 | 20 |
| >40th centile | 25 | 69 | 25 | 20 |
| OFC | ||||
| <3rd centile | 46 | 5 | 8 | 55 |
| 3rd–40th centile | 39 | 27 | 50 | 30 |
| >40th centile | 15 | 68 | 42 | 15 |
| BMI | ||||
| <3rd centile | 43 | 1 | 27 | 53 |
| 3rd–40th centile | 23 | 16 | 45 | 16 |
| >40th centile | 34 | 79 | 27 | 31 |
Scoliosis and clinical forms
| Scoliosis | % Classical | % Z-RTT | % Hanefeld | % Congenital | % ARTT-NOS |
|---|---|---|---|---|---|
| No deviation | 36.7 | 63.1 | 75 | 100 | 35 |
| Mild | 36.7 | 31.6 | 23.1 | – | 45 |
| Severe | 26.5 | 5.26 | – | – | 20 |
Movement domain and clinical forms
| Walking | % Classical ( | % Z-RTT ( | % Hanefeld ( | % Congenital ( | % ARTT-NOS ( |
| Walks | 21.6 | 36.8 | 15.4 | – | 10 |
| Walking impaired | 50.5 | 57.9 | 38.5 | – | 55 |
| Not walking | 27.8 | 5.3 | 46.1 | 100 | 35 |
| Use of hands | % Classical ( | % Z-RTT ( | % Hanefeld ( | % Congenital ( | % ARTT-NOS ( |
| Normal | 2 | 15.8 | – | – | – |
| Reduced | 54.6 | 78.9 | 61.5 | – | 65 |
| No | 43.4 | 5.3 | 38.5 | 100 | 35 |
| Stereotypies | % Classical ( | % Z-RTT ( | % Hanefeld ( | % Congenital ( | % ARTT-NOS ( |
| Absent | 4.2 | 21.05 | 15.4 | – | 15 |
| Mild | 46.3 | 42.1 | 61.5 | 100 | 50 |
| Dominant or constant | 49.5 | 36.8 | 23.1 | – | 35 |
Epilepsy and clinical forms
| Epilepsy | % Classical ( | % Z-RTT ( | % Hanefeld ( | % Congenital ( | % ARTT-NOS ( |
|---|---|---|---|---|---|
| Absent | 41.8 | 36.8 | – | 100 | 25 |
| Controlled by therapy | 40.8 | 57.9 | 61.5 | – | 60 |
| Barely or not controlled by therapy | 17.4 | 5.3 | 38.5 | – | 15 |
Epilepsy distribution and onset (in months) and clinical forms
| Epilepsy onset | Classical | Z-RTT | Hanefeld | Congenital | ARTT-NOS |
|---|---|---|---|---|---|
| Mean (SD) | 62.6 (43) | 49.4 (11.7) | 2.2 (1.6) | – | 49 (39.9) |
| Range | 1–216 | 36–72 | 1–7 | – | 2–108 |
Feeding problems and clinical forms
| % Classical ( | % Z-RTT ( | % Hanefeld ( | % Congenital ( | % ARTT-NOS ( | |
|---|---|---|---|---|---|
| Dysphagia | |||||
| None | 35.4 | 58 | 38.5 | – | 40 |
| Mild | 47.9 | 42 | 31 | 100 | 50 |
| Severe | 16.7 | – | 30.5 | – | 10 |
| Constipation | |||||
| None | 23.9 | 47.4 | 23.1 | – | 20 |
| Mild | 59.4 | 36.8 | 53.8 | 100 | 55 |
| Severe | 16.7 | 15.8 | 23.1 | – | 25 |
Sleep and clinical forms
| Sleep | % Classical | % Z-RTT | % Hanefeld | % Congenital | % ARTT-NOS |
|---|---|---|---|---|---|
| None | 66.7 | 78.9 | 38.5 | – | 40 |
| Mild | 17.7 | 21.1 | 46.1 | 100 | 45 |
| Severe | 15.6 | – | 15.4 | – | 15 |
ISS areas and clinical forms
| ISS areas | Classical | Z-RTT | Hanefeld | Congenital | ARTT-NOS | |
|---|---|---|---|---|---|---|
| Development | Mean (SD) | 4.2 (2.6) | 1.4 (1.4) | 4.4 (2.6) | 9 (−) | 5.5 (2.8) |
| Range | 0–8 | 0–5 | 2–8 | – | 0–9 | |
| M_SKEL | Mean (SD) | 2.6 (1.8) | 1.2 (1.1) | 1.5 (0.9) | 2 (−) | 2.4 (1.7) |
| Range | 0–6 | 0–5 | 0–3 | – | 0–5 | |
| Movement | Mean (SD) | 4.6 (1.4) | 3.4 (1.3) | 4.5 (1.1) | 6 (−) | 4.5 (1.5) |
| Range | 0–8 | 1–6 | 3–6 | – | 2–8 | |
| Cortical | Mean (SD) | 3.8 (1.1) | 2.5 (0.8) | 5.1 (1) | 4 (−) | 3.9 (0.9) |
| Range | 1–6 | 1–5 | 3–6 | – | 3–6 | |
| Brain | Mean (SD) | 4.3 (2) | 3.3 (1.8) | 4.5 (1.8) | 5 (−) | 5.1 (2.4) |
| Range | 1–9 | 0–7 | 2–8 | – | 1–10 | |
PBZ areas mean scores and clinical forms
| PBZ score | Classical | Z-RTT | Hanefeld | Congenital | ARTT-NOS | |
|---|---|---|---|---|---|---|
| Motor area | Mean (SD) | 13.3 (4.6) | 6.4 (3.8) | 16.3 (4.5) | 0 (−) | 11.8 (2.3) |
| Range | 5–24 | 0–15 | 12–22 | – | 8–14 | |
| S-C | Mean (SD) | 12.2 (4.6) | 8 (4.1) | 21.5 (5.7) | – | 14.2 (5.9) |
| Range | 3–23 | 1–15 | 16–32 | – | 8–25 | |
| Daily living | Mean (SD) | 10.2 8 (3.4) | 5.4 (3.4) | 11.8 (2.7) | – | 7.7 (2.8) |
| Range | 1–17 | 0–11 | 7–15 | – | 4–13 | |
| Total | Mean (SD) | 35.7 (9.8) | 19.8 (10.3) | 49.7 (11.2) | – | 33.7 (6) |
| Range | 13–62 | 2–41 | 40–69 | – | 27–44 | |
PBZ and severity in clinical forms, percentage
| PBZ areas | Severity scale | Classical | Z-RTT | Hanefeld | ARTT-NOS |
|---|---|---|---|---|---|
| Motor | Mild | 3.8 | 50 | – | – |
| Medium | 40.4 | 42.9 | – | 40 | |
| Severe | 40.4 | 7.1 | 50 | 60 | |
| Extreme | 15.4 | – | 50 | – | |
| S-C | Mild | 17.3 | 50 | – | – |
| Medium | 40.4 | 35.7 | – | 50 | |
| Severe | 34.6 | 14.3 | 50 | 30 | |
| Extreme | 7.7 | – | 50 | 20 | |
| Daily living | Mild | 7.7 | 42.9 | – | 20 |
| Medium | 30.8 | 42.9 | 16.7 | 60 | |
| Severe | 44.02 | 14.3 | 33.3 | 10 | |
| Extreme | 17.3 | – | 50 | 10 | |
| Total | Mild | 9.6 | 71,4 | – | – |
| Medium | 82.7 | 28.6 | 66.7 | 100 | |
| Severe | 7.7 | – | 33.3 | – | |
| Extreme | – | – | – | – |
Abnormal breathing and clinical forms
| % Breath abnomal | Classical | Z-RTT | Hanefeld | Congenital | ARTT-NOS |
|---|---|---|---|---|---|
| Mean (SD) | 50.8 (21.4) | 41.7 (17.7) | 57.1 (23.1) | 37.4 | 42.5 (24.4) |
| Range | 0–100 | 3–71.5 | 17.2–84.4 | – | 0–77 |
BMI centiles and cardiorespiratory phenotype
| BMI | Apneustic | Feeble | Forceful |
|---|---|---|---|
| <3rd centile | 30 % | 34 % | 42 % |
| 3rd centile–40th centile | 35 % | 22 % | 14 % |
| >40th centile | 35 % | 44 % | 23 % |
Cardio-respiratory phenotypes across clinical forms
| Phenotype | Classical | Z-RTT | Hanefeld RTT | Congenital | ARTT-NOS |
|---|---|---|---|---|---|
| Feeble | 37 % | 53 % | – | – | 50 % |
| Forceful | 49 % | 42 % | 80 % | 100 % | 39 % |
| Apneustic | 13 % | 5 % | 20 % | – | – |
| Normal | 1 % | – | – | – | 11 % |
Valsalva manoeuvre and clinical form
| Valsalva | Classical | Z-RTT | Hanefeld | Congenital | ARTT-NOS |
|---|---|---|---|---|---|
| Mean (SD) | 5.5 (9.8) | 0.6 (0.7) | 1.3 (1.9) | 0.2 (−) | 3 (7.8) |
| Range | 0–53.2 | 0–2.1 | 0–6.8 | – | 0–32.8 |
Heart rate (HR) by fenotype
| HR | Apneustic | Feeble | Forceful | Normal |
|---|---|---|---|---|
| Mean (SD) | 98.9 (15.8) | 91.3 (15.7) | 101.2 (17.4) | 90 |
| Range | 74–137.4 | 55–130 | 54–148 | – |
Heart rate and clinical form
| HR | Classical | Z-RTT | Hanefeld | Congenital | ARTT-NOS |
|---|---|---|---|---|---|
| Mean (SD) | 95.6 (16) | 94.2 (14.4) | 105.2 (24.6) | 148 (−) | 97.6 (13.6) |
| Range | 55–130 | 65–115 | 54–137,4 | – | 78–126 |
Vagal tone (CVT) and clinical form
| CVT | Classical | Z-RTT | Hanefeld | Congenital | ARTT-NOS |
|---|---|---|---|---|---|
| Mean (SD) | 5.6 (3.5) | 5.9 (2.4) | 6.1 (7.7) | 0.7 (−) | 6.4 (3.4) |
| Range | 1.2–20 | 3–13.1 | 0.9–28.9 | – | 1.9–15 |
Vagal tone and phenotype
| CVT | Apneustic | Feeble | Forceful | Normal |
|---|---|---|---|---|
| Mean (SD) | 5.5 (2.1) | 5.6 (2.4) | 9.2 (8.1) | 9,2 (8,1) |
| Range | 0.9–9.4 | 1.2–116 | 3.5–15 | 3.5–15 |
Clinical forms and genes
| Classical | Atypical | Total | ||||
|---|---|---|---|---|---|---|
| Hanefeld | Congenital | Z-RTT | ARTT-NOS | |||
| RTT male MECP2 + | – | – | – | – | 2/20 (10 %) | 2 |
| RTT females MECP2 + | 94/98 (96 %) | – | – | 18/19 (95 %) | 4/20 (20 %) | 116 |
| RTT females MECP2- | 4/98 (4 %) | – | – | 1/19 (5 %) | 13/20 (65 %) | 18 |
| CDKL5 + | – | 12 | – | – | – | 12 |
| CDKL5-e MECP2- | 1 | 1 | ||||
| FOXG1 + | – | – | 1 | – | – | 1 |
| MEF2C + | – | – | – | – | 1/20 (5 %) | 1 |
| TOTAL | 98 (100 %) | 13 (100 %) | 1 | 19 (100 %) | 20 (100 %) | 151 |
MECP2 mutations and clinical forms
| Mutations | Classical | Atypical | Tot | % | |
|---|---|---|---|---|---|
| Z-RTT | ARTT-NOS | ||||
| Substitutions | |||||
| Non sense | 29 | 1 | 1 | 31 | 26 % |
| Early truncating | 22 | – | 1 | 23 | |
| Late truncating | 7 | 1 | – | 8 | |
| Missense | 29 | 9 | 4 | 42 | 36 % |
| Large Deletions | 17 | – | – | 17 | 14 % |
| Frameshift | 19 | 8 | 1 | 28 | 24 |
|
|
|
| – |
| |
| 94 | 18 | 6 | 118 | 100 % | |
ISS total score and MECP2 mutations
| ISS total | Early truncating | Late truncating | Large deletion | Frameshift | Missense | C ter del |
|---|---|---|---|---|---|---|
| Mean (SD) | 21.3 (6.2) | 16.7 (4.7) | 19.2 (5.9) | 20.3 (7) | 18.4 (5.7) | 14.2 (6) |
PBZ total score and MECP2 mutations
| PBZ total | Early truncating | Late truncating | Deletions | Frameshift | Missense | C terminal del |
|---|---|---|---|---|---|---|
| Mean (SD) | 34.4 (13.5) | 33.4 (9.3) | 38.2 (8.8) | 42.7 (11.6) | 32.6 (9.9) | 23.4 (12) |